Recent Updates
Recently added Catalysts

pegylated liposomal doxorubicin

Phase 1

Prostate Cancer | Small molecule | Oncology |Imunon, Inc.|Last Updated: May 30, 2013

Success Probability
Subscribe to view
Market & Valuation
Subscribe to view
Trial Design
UNCONTROLLED
Total Trials1
Total Enrollment -
FDA Designations
No designations recorded
Clinical trial landscape

pegylated liposomal doxorubicin · 1 trial · 1 indication

Phase 1 1
NCT00061867Liposomal Doxorubicin and Thermal Therapy in Treating Patients With Prostate CancerProstate Cancer
COMPLETED- Analytics
PHASE1COMPLETED
Liposomal Doxorubicin and Thermal Therapy in Treating Patients With Prostate Cancer
Prostate Cancer
NCT00061867-
Unlock trial analytics
Study Design & Arms
MaskingNONE
PurposeTREATMENT
Interventions
NameTypeDescription
pegylated liposomal doxorubicin hydrochlorideDRUG -
hyperthermia treatmentPROCEDURE -
Unlock Study Design Details
Eligibility Criteria
Age Range40 Years to N/A
SexMALE
Healthy VolunteersNo
Study Sites2

DISEASE CHARACTERISTICS: * Histologically confirmed adenocarcinoma of the prostate * Rising prostate-specific antigen AND radiographic evidence of extraprostatic prostate cancer by bone scan, CT scan, prostascint scan, or MRI PATIENT CHARACTERISTICS: Age * 40 and over Performance status * Karn...

Countries:United States
Unlock Eligibility Criteria
Competitive Landscape -Prostate Cancer 256 trials

Top 20 of 54 competitors

CompanyTickerTrialsLead PhaseDrugs
AstraZeneca PLCAZN19PHASE3olaparib, abiraterone
Merck & Co., Inc.MRK6PHASE3Ifinatamab deruxtecan, Docetaxel, Prednisone
Pfizer Inc.PFE12PHASE3Talazoparib with enzalutamide
Johnson & JohnsonJNJ21PHASE3Apalutamide, Androgen Deprivation Therapy
Eli Lilly and CompanyLLY9PHASE3Abemaciclib, Abiraterone, Prednisone or Prednisolone
Amgen Inc.AMGN7PHASE3Xaluritamig, Abiraterone, Enzalutamide, Cabazitaxel
Novartis AG Sponsored ADRNVS27PHASE3177Lu-PSMA-617, 68Ga-PSMA-11, ARDT, ADT
Exelixis, Inc.EXEL4PHASE3Cabozantinib, Atezolizumab, Abiraterone, Enzalutamide, Prednisone
Candel Therapeutics, Inc.CADL3PHASE3Aglatimagene besadenovec, valacyclovir
Bristol-Myers Squibb CompanyBMY2PHASE3BMS-986365, Enzalutamide, Abiraterone, Docetaxel, Predinsone/Prednisolone
BioNTech SE Sponsored ADRBNTX1PHASE3BNT324, Docetaxel, Prednisone/prednisolone
Telix Pharmaceuticals Limited Sponsored ADRTLX3PHASE368Ga-PSMA-11
Sanofi SA Sponsored ADRSNY2PHASE3abiraterone, Docetaxel
Regeneron Pharmaceuticals, Inc.REGN4PHASE2REGN2810, Degarelix, Leuprolide, Docetaxel
Veracyte, Inc.VCYT2PHASE2Darolutamide, Zoladex, Zoladex LA, Decapeptyl sustained release, Depo-Eligard
Lantheus Holdings IncLNTH3PHASE3Undisclosed
Kyntra Bio, Inc.KYNB2PHASE2FG-3246
IDEAYA Biosciences, Inc.IDYA3PHASE1IDE-161, Pembrolizumab
Xencor, Inc.XNCR1PHASE2vudalimab
Arcus Biosciences, Inc.RCUS2PHASE2Atezolizumab, Tocilizumab, Etrumadenant
Unlock Competitive Intelligence